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Effect of interdisciplinary care on weight loss: A randomised controlled
trial
Abstract
Objective: To determine the effectiveness of a novel interdisciplinary treatment compared with usual care on
weight loss in overweight and obese adult volunteers. Design: Single blinded controlled trial. Participants
randomly assigned to usual care (C, general guideline-based diet and exercise advice), intervention (I,
interdisciplinary protocol) or intervention + a healthy food supplement (30 g walnuts/day) (IW). Setting:
Community based study, Illawarra region, south of Sydney, Australia. Participants: Generally well volunteer
adult residents, 25-54 years, body mass index (BMI) 25-40kg/m 2 were eligible. At baseline 439 were
assessed, 377 were randomised, 298 completed the 3-month intensive phase and 178 completed the
12-month follow-up. Interventions: Treatment was provided at clinic visits intensively (0 months, 1 month, 2
months, 3 months) then quarterly to 12 months. Support phone calls were quarterly. All participants
underwent blinded assessments for diet, exercise and psychological status. Primary and secondary: measures
The primary outcome was difference in weight loss between baseline and 12 months (clinically relevant target
5% loss). Secondary outcomes were changes in blood pressure, fasting blood glucose and lipids, and changes
in diet, exercise and psychological parameters. Results: At 12 months, differences in weight loss were
identified (p < 0.001). The I group lost more than controls at 3 months (91.11 (92.23,90.00), p < 0.05) and
the IW more than controls at 3 months (91.25 (92.35,90.15), p < 0.05) and 6 months (92.20 (93.90,90.49), p
< 0.01). The proportion achieving 5% weight loss was significantly different at 3 months, 6 months and 9
months (p=0.04, p=0.03, p=0.03), due to fewer controls on target at 3 months, 6 months and 9 months and
more IW participants at 6 months. Reductions in secondary outcomes (systolic blood pressure, blood
glucose/lipid parameters and lifestyle measures) followed the pattern of weight loss. Conclusions: An
interdisciplinary intervention produced greater and more clinically significant and sustained weight loss
compared with usual care. The intensive phase was sufficient to reach clinically relevant targets, but long-term
management plans may be required.
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Objective To determine the effectiveness of a novel 
interdisciplinary treatment compared with usual care on 
weight loss in overweight and obese adult volunteers.
Design  Single blinded controlled trial. Participants 
randomly assigned to usual care (C, general guideline-
based diet and exercise advice), intervention (I, 
interdisciplinary protocol) or intervention + a healthy food 
supplement (30 g walnuts/day) (IW).
Setting Community based study, Illawarra region, south of 
Sydney, Australia.
Participants Generally well volunteer adult residents, 
25-54 years, body mass index (BMI) 25-40kg/m2 were 
eligible. At baseline 439 were assessed, 377 were 
randomised, 298 completed the 3-month intensive phase 
and 178 completed the 12-month follow-up.
Interventions Treatment was provided at clinic visits 
intensively (0 months, 1 month, 2 months, 3 months) 
then quarterly to 12 months. Support phone calls were 
quarterly. All participants underwent blinded assessments 
for diet, exercise and psychological status. 
Primary and secondary measures The primary outcome 
was difference in weight loss between baseline and 12 
months (clinically relevant target 5% loss). Secondary 
outcomes were changes in blood pressure, fasting blood 
glucose and lipids, and changes in diet, exercise and 
psychological parameters.
Results At 12 months, differences in weight loss were 
identified (p<0.001). The I group lost more than controls 
at 3 months (91.11 (92.23,90.00), p<0.05) and the IW 
more than controls at 3 months (91.25 (92.35,90.15), 
p<0.05) and 6 months (92.20 (93.90,90.49), p<0.01). 
The proportion achieving 5% weight loss was 
significantly different at 3 months, 6 months and 9 
months (p=0.04, p=0.03, p=0.03), due to fewer controls 
on target at 3 months, 6 months and 9 months and more 
IW participants at 6 months. Reductions in secondary 
outcomes (systolic blood pressure, blood glucose/lipid 
parameters and lifestyle measures) followed the pattern 
of weight loss.
Conclusions An interdisciplinary intervention produced 
greater and more clinically significant and sustained 
weight loss compared with usual care. The intensive phase 
was sufficient to reach clinically relevant targets, but long-
term management plans may be required. 
Trial registration number ANZCTRN 12614000581662; 
Post-results. 
InTroducTIon
The prevention and management of chronic 
non-communicable disease (CNCD) is a chal-
lenge for health services.1Given the links to 
disease pathology, identifying overweight 
as a problem is an important first step.2 
Primary care is an ideal setting for the clinical 
management of obesity, yet relevant studies 
are scarce,3 and measuring or recording 
weight in this setting appears suboptimal.4 In 
addition, weight management may require a 
more shared sense of decision making,5 and 
a broader approach, including the expertise 
of relevant allied health professionals.6 For 
example, dietitians may provide expertise on 
nutritional factors other than dietary energy 
that influence weight loss and chronic disease 
risk factors,7 such as dietary patterns,8 signifi-
cant foods,9 and nutrients such as fibre,10 fatty 
acids11 and sodium.12
Health behaviours that can significantly 
lower disease risk are central to the manage-
ment of chronic disease.13 There is convincing 
evidence that focusing on diet, physical 
activity and behaviour will have the best effects 
on overweight.14 Obese individuals who lose 
Strengths and limitations of this study
 ► The study was closely aligned to practice and 
protocols tested could be readily translated into 
primary care services.
 ► Although this was a single-centre study, substantial 
controls were applied to provide quality evidence of 
effects.
 ► The study demonstrated the breadth of behavioural 
influences integral to achieving weight loss and 
clinical outcomes.
 ► Rigorous statistical analyses were applied to 
the evaluation of primary outcomes, including a 
sensitivity analysis to confirm effects.
 ► As practice-oriented research, retention strategies 
were not applied, with higher than anticipated loss 
to follow-up following the intensive phase.
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just 5% of their body weight (the target for American 
College of Cardiology/American Heart Association clin-
ical guidelines2) have significant improvements in risk 
factors for type 2 diabetes and cardiovascular disease, 
including improved insulin sensitivity and reduced fat 
in the liver.15 However, there are underlying metabolic 
problems and weight regain invariably follows.16 17 This 
suggests obesity itself is a chronic condition requiring 
acute effective treatments repeated at intervals16 with the 
provision of consistent positive reinforcement to address 
associated complex psychological factors.18 There is little 
research on holistic treatments that integrate diet, exer-
cise and psychological support19 and research is needed 
to test novel protocols in this area.20 21 In a feasibility trial 
comparing usual care with an interdisciplinary model, 
we found high eligibility (83%) and completion (87%) 
rates and a preliminary effect of −3.98 kg greater weight 
loss over 3 months (95% CI 6.17 to 1.79, p=0.002).22 The 
next research question was whether weight loss could be 
achieved in a larger cohort and over a longer time period. 
The objective of the current trial was to determine the 
effectiveness of a novel interdisciplinary treatment 
compared with usual care on weight loss in overweight 
and obese adult volunteers. We hypothesised that a 
model of care with physician oversight that integrates 
the expertise of dietitians, with exercise physiologists and 
psychologists will be more effective than general advice 
provided by a practice nurse (usual care). Further, the 
provision of a supplement of a significant healthy food 
may enhance this effect and influence the overall diet.
MeThods
study oversight
 The trial is registered with the Australian and New Zealand 
Clinical Trial Registry (ANZCTRN12614000581662). 
Study oversight was provided by the senior clinical inves-
tigative team.
study participants
Recruitment was conducted through communications 
and advertising in the local media. Respondents who 
were permanent residents of the Illawarra region, aged 
25–54 years, community dwelling and with a body mass 
index (BMI) 25–40 kg/m2 were included. Exclusion 
criteria were being unable to communicate in English; 
having severe medical conditions impairing the ability 
to participate in the study or thought to limit survival to 
1 year, having reported illegal drug use or regular alcohol 
intake associated with alcoholism (>50 g/day); or other 
major impediments to participation.
Trial design
This was a community-specific (single-centre), 
randomised, assessor blinded trial, comparing outcomes 
between intervention and control groups at 0 months, 
3 months, 6 months, 9 months, 12 months. Full details 
of the study protocol and baseline results are reported 
elsewhere.23 Briefly, all participants attended the clinic 
for counselling on seven occasions (0 months, 1 months, 
2 months, 3 months, 6 months, 9 months, 12 months) 
and received quarterly support phone calls. Assessment 
and treatment protocols were devised by the research 
team including physicians, dietitians, exercise physiolo-
gists and psychologists. Measurements were undertaken 
separately at these time points. Body weight (kg) was 
measured at each visit in an upright position (minimal 
clothing, no shoes) using scales with a bioelectrical 
impedance component for estimating body fat (%) 
(Tanita TBF-662, Wedderburn, Ingleburn, New South 
Wales, Australia). Systolic blood pressure (SBP) and 
diastolic blood pressure were measured at 0 months, 3 
months and 12 months using the Omron BP-203RPEIII 
VP-1000 device (Omron Healthcare, Kyoto, Japan). 
Measurements are collected at the end of 5 min resting 
period in supine position. Fasting blood lipids (choles-
terol, low-density lipoprotein (LDL), high-density 
lipoprotein (HDL), triglycerides), fasting blood glucose 
and serum HbA1c were assessed through a registered 
pathology service (Southern IML Pathology) quarterly. 
For 24 hours urinary sodium assessments, a 24 hours 
urine sample was provided at 0 months, 3 months and 
12 months. Dietary intake was assessed using a diet history 
interview24 and physical activity using the International 
Physical Activity Questionnaire (IPAQ)25 and via a pedom-
eter (Yamax Digiwalker SW200, Pedometers Australia) 
worn for a 4-day period every quarter. A range of psycho-
logical assessments were applied, including the Physical 
and Mental Health 12-Item Short-Form Health Survey 
(SF-12) (12 questions),26 Depression Anxiety Stress Scale 
(short form 21 questions),27 and Acceptance and Action 
Questionnaire for Weight-related problems (11 ques-
tions) (AAQW)28 at 0 months, 3 months and 12 months.
Participants were randomly assigned to usual care (C, 
general advice), intervention (I, interdisciplinary advice) 
and intervention + food supplement (IW, I+30 g walnuts/
day). Usual care involved a nurse providing general 
advice based on the Australian Guide to Healthy Eating 
(AGHE)29 and National Physical Activity Guidelines.30 
Phone contact at quarterly intervals was also made by the 
study administrator delivering semiscripted patient-cen-
tred support of short duration. In the intervention 
counselling session an accredited practising dietitian 
negotiated changes in specific food choices based on 
a diet history assessment and materials that referred to 
the food groups outlined in AGHE (vegetables, fruits, 
grains, protein rich foods, dairy foods, oils). This consul-
tation included advice to increase physical activity and 
reduce sedentary behaviour by identifying opportuni-
ties in leisure, occupation and household activities, with 
additional categorical guidance prepared by the exercise 
physiologist following exercise assessment. The psychol-
ogist developed a workbook for participants and trained 
health coaches to deliver related scripted calls of short 
(15 min) duration at quarterly intervals. The psycholog-
ical coaching component was based on principles from 
Acceptance and Commitment Therapy31 and involved 
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clarification of underlying values to increase motiva-
tion related to weight loss, increasing mindfulness and 
awareness to facilitate better health choices, and self-com-
passion to promote continued valued-action even in the 
presence of setbacks.
Randomisation was performed remotely in randomly 
allocated blocks of three, six or nine by an investigator 
unrelated to the clinic. A computer generated rando-
misation sequence was used (STATA V.12, StataCorp, 
College Station, Texas, USA). The randomisation was 
stratified according to sex and BMI (low BMI ≤30 and 
high BMI >30). The randomisation list was provided to 
the study team who added eligible participants sequen-
tially for each of the strata. Participants were blinded to 
their randomised allocation and only advised they would 
be seen by a health practitioner.
effectiveness outcomes
All end points compared baseline data with 12-month 
results. The primary outcome was body weight (kg). 
Secondary outcomes were fasting blood lipids, glucose 
and haemoglobin A1c (HbA1c), SBP, dietary intake, 
measures of physical activity and psychological well-
being.
statistical analysis
Outcomes were analysed using mixed models. The 
primary outcome variable weight was analysed using a 
published model building procedure.32 Initially a simple 
model with main effects and a group by time interac-
tion was considered. Initial data exploration suggested 
quadratic and cubic terms may be needed and these were 
added in turn and tested with likelihood ratio tests to 
determine improvement in model fit. Random effects 
for both intercept and slope were included in the weight 
model. A similar procedure was followed for all other 
variables. Significant higher order interaction terms 
were followed up by analysis of covariance (ANCOVA) 
to determine differences between groups at each time 
point with baseline value as a covariate. Gender was 
included as a covariate in the body composition models. 
As the dropout rate at the end of the follow-up period 
(12 months) was substantial, several sensitivity anal-
yses were performed. First multiple imputation of 
100 data sets was used to verify the significance of the 
difference between the groups at all time points. The 
imputation model included group, age and gender, 
as well as weight at each time point. A complete case 
analysis, last observation carried forward (LOCF) and 
baseline observation carried forward (BOCF) were also 
performed. Model building was performed using LMER 
in the LME4 package of R (RStudio V.0.99.489, RStudio). 
Multiple Imputation was performed in SAS (V.9.4 SAS 
Institute, Cary, North Carolina, USA) using PROC MI, 
PROC MIXED and MIANALYSE, for the ANCOVA. 
F tests for the 100 multiple imputations using PROC 




Recruitment began in May 2014 and the last partici-
pant completed in May 2016. Surveys were sent to 718 
respondents, 439 of whom underwent baseline assess-
ments. n=377 were randomised into the C (n=126), I 
(n=125) and IW groups (n=126). The intensive phase 
was completed by 298 participants (withdrawal rate 18%) 
and the 12 months follow-up by n=178 participants (with-
drawal rate 39%) (figure 1). Screening and baseline data 
are reported elsewhere.23 The sample comprised mostly 
obese (BMI 32 (29–35) kg/m2), non-smoking (98%) 
well educated (85% postschool qualifications) women 
(74%) of median age 45 (37–51) years. They also suffered 
from anxiety (26.8%) and depression (33.7%) and were 
treated for hypertension (25%). Metabolic syndrome was 
identified in 34% of participants.33
Participants attended the Clinical Trials Unit of the 
Illawarra Health and Medical Research Institute. After 
randomisation 67 participants withdrew, with most (75%) 
citing an inability to commit time and/or personal 
reasons. The next major withdrawal (n=49) occurred 
after the 3-month intensive phase for similar reasons. 
Attendance gradually reduced for all groups but IW 
participants attended more, and were more likely to 
complete the phone coaching calls than the I group (at 
quarters 2, 3, 4; p<0.05). Less than a quarter of partici-
pants were on medications for glucose, lipids and blood 
pressure. There were no differences between groups for 
medication use (p>0.05) (table 1).
Primary outcomes
Weight loss
After 12 months weight reduced in all groups with 
a significant difference between groups (p=0.0002) 
(tables 2 and 3). The primary analysis model including 
group, gender and time, found a quadratic time by 
group interaction. The effect was seen with the IW 
group showing initial weight loss and then a gain from 
6 months, while the other groups maintained their weight 
loss over time (figure 2). Post hoc analysis on complete 
cases indicated significantly greater weight loss in I and 
IW compared with C at 3 months (−1.2 kg, p=0.045 I; 
−1.3 kg, p=0.025 IW) and at 6 months for IW (−2.1 kg; 
p=0.010). The ANCOVA compared the groups using 
a mixed model on the actual data and the combined 
estimates for 100 imputations (table 2 and supple-
mentary materials). A sensitivity analysis confirmed 
the effects (table 3). An ANCOVA on complete cases 
for the 12-month weight change adjusted for baseline 
weight, gender and age showed an effect approaching 
significance p=0.056 reflecting a difference between the 
C-IW group of −2.2 kg (95% CI −4.6 to 0.1 kg, p=0.068) 
compared with differences between the C-I groups 
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−1.9 kg (95% CI −4.5 to 0.7 kg, p=0.228) and the I and 
IW groups −0.3 kg (95% CI −2.8 to 2.2 kg, p=1.00).
Achievement of 5% weight loss target
χ2 Analyses indicated significant differences in the 
proportion of participants achieving the clinically signif-
icant effect of 5% weight loss. At 3 months, 6 months 
and 9 months the proportion achieving 5% weight loss 
in the C group was lower than expected (p=0.04, 0.03, 
0.03, respectively), although there was no difference at 
12 months (p=0.091) with 33% IW, 38% I and 20% C 
meeting the 5% target. At 6 months the number in the 
IW group was higher than expected (p=0.03), consistent 
with the primary analysis. Likewise there was a group 
difference in change in per cent body fat (interaction 
effect p=0.022) (table 2).
secondary outcomes
Clinical effects
SBP decreased between baseline and 3 months but then 
remained unchanged (table 2). Changes in SBP also 
reflected patterns of sodium excretion (a marker of 
dietary intake) decreasing from baseline to 3 months 
(p<0.001) and increasing to 12 months (p=0.002). Like-
wise, fasting blood glucose was lower than baseline at 
3 months (p=0.040) and 6 months (p<0.001), and then 
remained lower than 12 months (p=0.003). HbA1c at 
12 months was lower than the baseline value (p=0.031).
Figure 1 Participant flow in the HealthTrack randomised controlled trial.
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In keeping with this pattern of effects, total choles-
terol and LDL concentrations were lowest for the sample 
at 3 months (p<0.001; p≤0.031, respectively) and at 
6 months they remained lower than baseline (p=0.020; 
p=0.034, respectively). The cholesterol: HDL ratio 
decreased particularly after 6 months, while HDL- values 
first dropped at 3 months then returned to greater than 
baseline at 12 months (p≤0.021). The group effect for 
total cholesterol showed a lower overall mean for the IW 
group compared with controls (p=0.001) and I (p=0.037) 
(table 2).
Behavioural effects
As with the pattern of weight change, reported energy 
and total fat intakes (as a per cent of energy) were lower 
than baseline at 3 months (p<0.001) and still at 12 months 
(p<0.001), but they increased between 3 months and 
12 months (p=0.020) (table 2). Changes in per cent 
energy from protein were the opposite for dietary fat. 
The value was higher than baseline at 3 months and 
12 months (p<0.001), but lower at 12 months than 
3 months (p=0.04). Per cent energy from carbohydrate 
reduced from baseline to 12 months (p=0.002), and from 
alcohol (p=0.012) decreased from baseline to 12 months 
(p=0.041). The only reported difference between groups 
was for the polyunsaturated:saturated (P:S) fatty acid 
ratio, where the the IW group showed a higher value over 
time compared with the other groups (interaction effect 
p<0.001).
The time effects for increased physical activity were 
stronger in self-reported MET-Mins/week (IPAQ) 
(p<0.001; significantly higher than baseline at all time 
points, table 2) than measurements of steps/day (p=0.046) 
(supplementary materials). The changes in diet and phys-
ical activity were accompanied by increases in scores for 
positive psychological parameters (Quality of Life, QoL, 
table 2) and decreases for negative parameters (DASS-
21; AAQW, supplementary materials). The IW group 
scored highest for QoL (SF-12) physical summary scores 
throughout the study period (group effect p=0.027). 
The QoL (SF-12) mental summary score increased after 
3 months, with differences from baseline to 12 months 
(time effect p=0.002). The DASS-21 and AAQW scores 
were lower at 12 months (p<0.001) but the significant 




Despite the same intensity of intervention and a focus 
on national diet and physical activity guidelines, the 
interdisciplinary protocol produced greater and more 
clinically significant effects on weight loss than usual 
care (figure 2). Although there were repeated attempts 
to retrieve participants who failed to attend visits, attri-
tion was higher than expected, so multiple approaches 
including random effects mixed model analyses were 
applied as this would assure quality reporting required of 
clinical trials.34 The ANCOVA compared the groups using 
a mixed model on the actual data and the combined esti-
mates for 100 imputations (table 2 and supplementary 
Table 1 Number (%) of participants reporting medication during the HealthTrack study
Medication type Control Intervention Intervention + walnuts p value*
Antihypertensive (n (%))
  Baseline 14 (11) 20 (16) 17 (14) 0.521
  3 months 10 (10) 16 (16) 17 (17) 0.410
  6 months 7 (10) 10 (15) 12 (14) 0.654
  9 months 6 (10) 8 (15) 13 (17) 0.491
  12 months 6 (10) 9 (20) 13 (18) 0.267
Hypoglycaemic/insulin (n (%))
  Baseline 6 (5) 4 (3) 5 (4) 0.945
  3 months 6 (6) 3 (3) 5 (5) 0.584
  6 months 2 (3) 2 (3) 4 (5) 0.819
  9 months 1 (2) 3 (6) 3 (4) 0.563
  12 months 1 (2) 3 (7) 3 (4) 0.429
Hypolipidaemic (n (%))
  Baseline 15 (12) 10 (8) 7 (6) 0.201
  3 months 14 (15) 8 (8) 7 (7) 0.147
  6 months 10 (14) 6 (9) 5 (6) 0.190
  9 months 9 (15) 6 (11) 5 (7) 0.287
  12 months 10 (16) 5 (11) 3 (4) 0.064
*χ2 test
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materials). A sensitivity analysis confirmed the effects 
(table 3) using multiple imputation (using groups, age, 
gender and weight at each time point), LOCF and BOCF 
techniques. As interaction terms were significant using all 
approaches, we were confident of the effects observed.
While it is not possible to separate out the components 
of the interdisciplinary approach, it appears more indi-
vidualised advice including a focus on specific foods may 
have enhanced the effect. This was especially evident with 
the food supplemented group who continued to produce 
a greater weight loss at 6 months. The size of the effect 
and the time taken to achievement are also highly rele-
vant to practice. The effects were similar to those reported 
in a systematic review of weight loss interventions which 
found that for combined diet and exercise interventions 
ranging from 12 months to 18 months, mean weight losses 
ranged from 0.3 kg to 5.9 kg for women and 4.2–7.3 kg for 
men.35 Without unusual retention strategies, we found 
that a 3-month commitment to an intensive treatment was 
feasible, and in that time the intervention protocol deliv-
ered a greater proportion with a 5% weight loss target. In 
Western societies, it is estimated that the adult population 
gains 0.45 kg weight/year,36 so our effects could be inter-
preted as even greater. Had we continued with monthly 
rather than quarterly clinic visits after 3 months we may 
have improved retention and study power, but that would 
meant greater healthcare costs. A simple sample size 
calculation based on the differences between groups for 
the completers at 12 months indicates that approximately 
124 subjects per group would be required to complete 
the study for differences between the three groups to 
be statistically significant when adjusted for multiple 
comparisons.
secondary outcomes
We confirmed the observation that a 5% weight loss 
can have an impact on disease risk factors.15 Signifi-
cant reductions in SBP occurred with weight loss, as 
expected, but this also occurred with increased physical 
activity, improved mental health scores and a reduction 
in urinary sodium, a dietary factor known to be associated 
with blood pressure.37 The latter implies that the dietary 
changes went beyond that of energy restriction. As the 
national dietary guidelines were a reference point for all 
groups, differences in sodium intakes were not observed 
in this intention-to-treat analysis. Per protocol analyses 
may be able to detect whether greater changes occurred 
in the groups with the dietitian (I and IW) confirming 
effects seen in other primary care studies.38 Similarly the 
improvements in blood glucose parameters occurred with 
weight loss in the presence of increased physical activity 
and a reduced carbohydrate load for the study cohort. 
Further research on the types of carbohydrate-rich foods 
may be informative in detecting more specific differences 
between groups.
The changes in blood lipids were as expected with 
changes in weight. The lower overall mean for total 
cholesterol for the IW group occurred in the presence 
of a significantly different dietary P:S ratio. We have 
previously shown that integrating walnuts in an energy 
controlled diet can change the dietary P:S ratio with 
concomitant effects on lipids.39 Given that walnuts are a 
fat-rich food, their inclusion in the dietary modelling for 
the IW group would be expected to influence the overall 
diet profile.
Implications for practice
Practice involves an integration of evidence on many 
factors, and in this research we examined a number 
of components. We confirmed that changes in disease 
risk factors occurred alongside changes in body weight, 
physical activity, mental health scores and dietary factors 
known to have an impact on disease risk such as dietary 
sodium, fibre and fatty acid profile.10 12 16 40 In this trial 
the dietitian provided face-to-face counselling with 
participants. Being more specific about actual foods 
to be consumed may be more effective and providing 
significant healthy food (walnuts) emphasised this point. 
While the effects of walnuts in the diet can be found in 
Figure 2 Difference in change in weight, weight change, 
and % body fat over time.
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the literature,39 41 there may have been synergistic effects 
with psychological factors in our trial. The reduced 
psychological avoidance of weight related issues (AAQW 
scores) was particularly relevant and further analyses of 
our data may clarify the effects of health coaching when 
integrated into diet and physical activity advice. In addi-
tion, and based on our previous research,42 the greater 
initial weight loss achieved by the IW group may have 
influenced retention, and this may have also resulted in 
the higher QoL scores, but it is difficult to determine 
if the provision of the food supplement alone acted as 
the main incentive.43 The greater attendance at phone 
coaching sessions by the IW group, which targeted skills 
in mindfulness and acceptance, also may have helped 
deal with the stress associated with achieving health 
goals.18 It is difficult to tease out any singular effect as 
there is so much interdependence between behavioural 
factors, but this study has helped expose significant 
elements. The pattern of weight loss reflected reduced 
energy intake and increased physical activity (table 2), 
providing evidence for applying expertise in both diet 
and exercise.44 45 As sources of nutrients, the food 
choices drove nutritional changes underpinned by the 
involvement of dietitians.46 47
strengths and limitations
The sample comprising volunteers from the community 
attending a single clinic was a limitation, and, although 
the proportion of individuals not speaking English 
well in the primary recruitment area was relatively low 
(approximately 3%),48 excluding these individuals may 
have further minimised access to a high-risk group. As 
a case study in planning services, however, the recruit-
ment strategy gave us an indication of who might attend 
for these types of treatment. The study was testing an 
approach applicable to primary care, so the analysis was 
conducted on an intention-to-treat basis rather than on 
compliance to treatment. In addition there was a high 
level of control of potential confounding variables. The 
design where all groups received the same intensity 
of intervention with dietary advice referring to foods 
in AGHE29 may have masked our ability to show true 
effects. In similar highly controlled circumstances it has 
been argued that for every kg increase in weight loss 
by controls, treatment effects may be reduced by about 
0.3 kg49.
While weight loss was observed, the lack of between-
group differences in reported energy intakes may 
reflect inaccuracies in dietary reporting and limitations 
in databases for estimating food energy. For example, 
the available energy from walnuts has been measured 
as 20% less than conventional estimates,50 and this may 
relate to other whole foods.51 The between-group differ-
ences in weight loss are plausible from the literature.8 52 
Like other research in this area,8 53 this study confirms 
the benefit of thinking beyond energy restriction, 
where other dietary factors act in synergy to influence 
outcomes.
The trial was aligned to translation to practice, so 
we did not employ enhanced retention strategies, 
but we know that early weight loss and age >50 years 
may predict retention.42 While we observed consid-
erable participant dropout which was predominantly 
due to time constraints and personal reasons, partic-
ipant dropout is common in weight loss trials.54 We 
also compared a number of missing data analysis 
techniques via sensitivity analyses.54 Research indi-
cates that psychological and behavioural factors 
appear more aligned with attrition than other back-
ground participant characteristics,55 something we 
aim to study further with this data set. In the evalua-
tion survey of the trial, participants indicated general 
approval of the approach and the three most listed 
positive features were individual attention, the health 
practitioner and the education provided (data not 
shown). Research indicates that, as part of chronic 
disease management, avoidance of weight gain may 
reduce healthcare costs in the long term.56 Four visits 
within the 3-month model of care could fit within the 
current annual Australian Medicare arrangements,57 
although with considerations for eligibility, and 
possible co-payments. These aspects all require confir-
matory research. Research is also needed on whether 
attending for 3 months would be sufficient to achieve 
this initial target, acknowledging that a ‘flattening’ of 
effects after 6 months is typical and reflects metabolic 
and behavioural adaptations.16 17
This study addressed a research gap providing 
evidence for developing effective healthcare teams 
in chronic disease management.20 21 Further analyses 
will be able to examine motivation and commitment 
barriers that both participants and healthcare teams 
must face. It is acknowledged that addressing long-term 
behaviour change is difficult in primary care,58 and that 
a lack of motivation and incentives may hinder trials on 
novel lifestyle interventions.59 Our trial recruited from 
the community, but medical supervision and commu-
nications with primary care physicians was part of the 
safety management, and provided insights into transla-
tion.
conclusion
The primary care context provides many opportu-
nities for dealing seriously with weight management 
as a health issue. Excess body weight is linked to the 
pathology of major CNCD, and is influenced by both 
physiological and behavioural factors. More research 
with greater consolidation of interdisciplinary exper-
tise, and establishing greater integration with medical 
and nursing practices will assist translation into primary 
care. Familiarity in standards of operation for the 
various professions building a full appreciation of 
knowledge and skills is required. Promoting opportuni-
ties to collaborate and providing guidelines60 are a start 
to developing long-term plans.
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